|
已选(0)清除
条数/页： 排序方式： |
| Emerging transporter-targeted nanoparticulate drug delivery systems 期刊论文
ACTA PHARMACEUTICA SINICA B, 2019, 卷号: 9
-
  收藏 | 浏览/下载：31/0 | 提交时间：2020/10/26
BLOOD-BRAIN-BARRIER POLY(ETHYLENE GLYCOL)-CO-POLY(TRIMETHYLENE CARBONATE) MESOPOROUS SILICA NANOPARTICLES ORAL DELIVERY SIRNA DELIVERY TUMOR HETEROGENEITY CHOLINE TRANSPORTER DOCETAXEL DELIVERY LOADED LIPOSOMES OLEATE PRODRUG Transporter Nano-DDS Oral delivery Brain-targeting Tumor-targeting |
| Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy 期刊论文
Cancer Biology & Medicine, 2018, 卷号: 15
作者: Tian Ye; Sun Changyu; Zhang Limeng; Pan Yuan
收藏 | 浏览/下载：74/0 | 提交时间：2020/12/28
MiRNA-106a NSCLC cisplatin gemcitabine chemotherapy resistant Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| Management of extramedullary plasmacytoma: Role of radiotherapy and prognostic factor analysis in 55 patients 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29
-
收藏 | 浏览/下载：23/0 | 提交时间：2020/10/26
SOLITARY PLASMACYTOMA RADIATION-THERAPY CLINICAL-FEATURES ONCOLOGY-GROUP SOFT-TISSUE NECK HEAD BONE MULTICENTER GUIDELINES Extramedullary plasmacytoma prognostic factors radiotherapy multiple myeloma |
| Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29
-
收藏 | 浏览/下载：30/0 | 提交时间：2020/10/26
EGFR MUTATIONS GEFITINIB TREATMENT 1ST-LINE TREATMENT OPEN-LABEL RARE MULTICENTER ERLOTINIB GENE CHEMOTHERAPY EFFICACY Non-small cell lung cancer EGFR uncommon mutation target therapy |
| Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice 期刊论文
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2017, 卷号: 18
-
收藏 | 浏览/下载：25/0 | 提交时间：2020/10/26
RANDOMIZED PHASE-III NEOADJUVANT CHEMOTHERAPY ENCAPSULATED DOXORUBICIN 1ST-LINE CHEMOTHERAPY PROGNOSTIC MARKER PLUS DOCETAXEL COMBINATION CYCLOPHOSPHAMIDE TRASTUZUMAB PACLITAXEL Liposomal doxorubicin Breast cancer Adjuvant chemotherapy Therapeutic effect Toxic and side effects |
| A pilot phase II study of neoadjuvant triplet chemotherapy regimen in patients with locally advanced resectable colon cancer 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2016, 卷号: 28
-
收藏 | 浏览/下载：26/0 | 提交时间：2020/10/26
METASTATIC COLORECTAL-CANCER 1ST-LINE TREATMENT ADJUVANT CHEMOTHERAPY PATHOLOGICAL RESPONSE LIVER METASTASES STAGE-II OXALIPLATIN FLUOROURACIL LEUCOVORIN IRINOTECAN 5-Fluorouracil colon cancer irinotecan oxaliplatin neoadjuvant chemotherapy |
| Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma 期刊论文
CHINESE JOURNAL OF CANCER, 2016, 卷号: 35
-
收藏 | 浏览/下载：23/0 | 提交时间：2020/10/26
CONCURRENT CHEMORADIOTHERAPY PROGNOSTIC-FACTORS RADIATION-THERAPY NECK-CANCER REIRRADIATION CHEMOTHERAPY SURVIVAL METAANALYSIS RETREATMENT HEAD Recurrence Nasopharyngeal carcinoma Intensity-modulated radiation therapy Concomitant chemoradiotherapy Cisplatin |
| Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system 期刊论文
CHINESE JOURNAL OF CANCER, 2015, 卷号: 34
-
收藏 | 浏览/下载：35/0 | 提交时间：2020/10/26
PRIMARY TUMOR VOLUME EPSTEIN-BARR-VIRUS RADIOFREQUENCY ABLATION PROGNOSTIC-FACTORS RADIATION-THERAPY LIVER METASTASES STAGING SYSTEM SURVIVAL CANCER CHEMOTHERAPY Nasopharyngeal carcinoma TNM staging Metastasis Prognosis |
| The formation of intracellular nanoparticles correlates with cisplatin resistance 期刊论文
SCIENCE CHINA-MATERIALS, 2015, 卷号: 58
-
收藏 | 浏览/下载：14/0 | 提交时间：2020/10/26
GLUTATHIONE-S-TRANSFERASE SQUAMOUS-CELL CARCINOMA LOCALLY ADVANCED HEAD PLATINUM NANOPARTICLES NECK-CANCER MOLECULAR-MECHANISMS DRUG-RESISTANCE CHEMOTHERAPY CYTOTOXICITY NANOMATERIALS |
| Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer 期刊论文
CHINESE JOURNAL OF CANCER, 2015, 卷号: 34
-
收藏 | 浏览/下载：32/0 | 提交时间：2020/10/26
PREOPERATIVE CHEMORADIATION TUMOR RESPONSE POSTOPERATIVE CHEMORADIOTHERAPY MESORECTAL EXCISION TRIAL RADIOTHERAPY RESECTION INTERVAL THERAPY CAPECITABINE Rectal cancer Pathologic complete response Neoadjuvant chemoradiotherapy Carcinoembryonic antigen Interval |
